REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $392,000 | – | 700 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Garda Capital Partners LP | 3,500 | $2,880,360 | 0.13% |
| GROUP ONE TRADING, L.P. | 31,900 | $26,252,424 | 0.09% |
| SIMPLEX TRADING, LLC | 33,500 | $27,569 | 0.02% |
| IMC-Chicago, LLC | 26,500 | $21,808,440 | 0.02% |
| Allianz Asset Management GmbH | 12,400 | $10,204,704 | 0.02% |
| SG Americas Securities, LLC | 16,700 | $1,142 | 0.01% |
| JANE STREET GROUP, LLC | 42,400 | $34,893,504 | 0.01% |
| JPMORGAN CHASE & CO | 32,900 | $27,075,384 | 0.00% |
| Focused Wealth Management, Inc | 400 | $12,441 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |